We serve Chemical Name:2-bromo-1-(1-methylbenzimidazol-2-yl)ethanone CAS:56653-43-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-bromo-1-(1-methylbenzimidazol-2-yl)ethanone
CAS.NO:56653-43-1
Synonyms:2-(2-bromoacetyl)-N-methylbenzimidazole;2-(bromoacetyl)-1-methylbenzimidazole;2-bromo-1-(1-methyl-1H-benzoimidazol-2-yl)ethanone;1-Methyl-2-bromacetyl-benzimidazol;2-bromo-1-(1-methyl-1H-benzimidazol-2-yl)-ethanone;2-bromo-1-(1-methyl-1H-benzimidazol-2-yl)-1-ethanone
Molecular Formula:C10H9BrN2O
Molecular Weight:253.09500
HS Code:2933990090
Physical and Chemical Properties:
Melting point:100ºC
Boiling point:371.9ºC at 760 mmHg
Density:1.57g/cm3
Index of Refraction:1.65
PSA:34.89000
Exact Mass:251.99000
LogP:2.15090
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(2-bromoacetyl)-N-methylbenzimidazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-1-(1-methyl-1H-benzimidazol-2-yl)-1-ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-1-(1-methyl-1H-benzimidazol-2-yl)-ethanone Use and application,2-bromo-1-(1-methyl-1H-benzimidazol-2-yl)-ethanone technical grade,usp/ep/jp grade.
Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 2-bromo-1-(1-methylbenzimidazol-2-yl)ethanone manufacturer Ultimately there’s likely a broad mix of social, cultural and economic drivers at play, suggested Lona Sandon, program director of the Department of Clinical Nutrition in the School of Health Professions at the UT Southwestern Medical Center in Dallas. She was not part of the research. 2-bromo-1-(1-methylbenzimidazol-2-yl)ethanone supplier Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. 2-bromo-1-(1-methylbenzimidazol-2-yl)ethanone vendor Ultimately there’s likely a broad mix of social, cultural and economic drivers at play, suggested Lona Sandon, program director of the Department of Clinical Nutrition in the School of Health Professions at the UT Southwestern Medical Center in Dallas. She was not part of the research. 2-bromo-1-(1-methylbenzimidazol-2-yl)ethanone factory Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.
